Search Results | Litt's Drug Eruption and Reaction Database

The most comprehensive database on adverse drug reactions for our profession.David Adams MD

Log in

Menu

Login

Home
About About
Alerts
Litt’s App
Contact Us
Help
Subscribe Subscribe
- Individual Subscription
- Institutional Subscription

Drugs belonging to restart save

class – Anti-obesity / weight loss pharmacotherapy – 15 items found

Search:

show all
0–9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Bupropion Compare:

Liraglutide Compare:

Lorcaserin Compare:

Mazindol Compare:

Methamphetamine Compare:

Naltrexone Compare:

Orlistat Compare:

Phendimetrazine Compare:

Phentermine Compare:

Rimonabant Compare:

Semaglutide Compare:

Setmelanotide Compare:

Sibutramine Compare:

Tirzepatide Compare:

Topiramate Compare:

Loading more results

No more results to show

Adverse reactions attributed to entire drug class 'Anti-obesity / weight loss pharmacotherapy'

Please login to view adverse reactions.

Serotonin syndrome

(2025): Yi W+, Medicine (Baltimore) 104(15), e41626 (1 case / female) (with fluoxetine) (with underlying comorbidities)

Gastrointestinal adverse reaction

(2025): Guo H+, Obes Pillars Jan (e-Collection) [REVIEW]

Adverse effects / adverse reactions

(2025): Liu L+, EClinicalMedicine Jan (e-Collection) [REVIEW]

Saved Searches Watched Drugs

Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone! If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Help
Terms & Conditions
Privacy
Disclaimer
Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.